Skip to main content
. 2022 Apr 20;269(7):3892–3898. doi: 10.1007/s00415-022-11102-1

Table 1.

Clinical and demographical features of FMD patients without and with triggers

Variable Total (n = 100) NoT-FMD (n = 12) T-FMD
(n = 88)
Group comparison
Sex, female, no. (%) 82 (82) 11 (91.6) 71 (80.7) 1.000F
Age, years, mean (SD) 41.4 (16) 50 (14.4) 39.7 (15.2) 0.016 M

Time since onset of symptoms to

FMD diagnosis, years, mean (SD)

4.2 (4.7) 5.3 (6) 4.1 (4.5) 0.673 M
FMD phenotype, no. (%)
 Weakness 89 (89) 11 (91.7) 78 (88.6) 1.000F
 Gait disorders 76 (76) 6 (50) 70 (79.5) 0.035F
 Tremor 69 (69) 7 (58.3) 62 (70.5) 0.507F
 Dystonia 34 (34) 2 (16.7) 32 (36.4) 0.213F
 Jerks 21 (21) 2 (16.7) 19 (21.6) 1.000F
 Facial movement disorders 19 (19) 1 (8.3) 18 (20.5) 0.454F
 Parkinsonism 4 (4) 0 4 (4.5) 1.000F
Self-reported non-motor symptoms, no. (%)
 Fatigue 78 (78) 9 (75) 69 (78.4) 0.723F
 Pain 72 (72) 10 (83.3) 62 (70.5) 0.501F
 Headache 56 (56) 5 (41.7) 51 (58) 0.286C
 Anxiety 51 (51) 4 (33.3) 47 (53.4) 0.192C
 Insomnia 41 (41) 5 (41.7) 36 (40.9) 1.000F
 Depersonalization/derealization 33 (33) 2 (16.7) 31 (35.2) 0.327F
 Panic attacks 24 (24) 2 (16.7) 22 (25) 0.725F
 Neurological comorbidities, no. (%) 20 (20) 2 (16.7) 18 (20.5) 1.000F
 Non-neurological comorbidities, no. (%) 45 (45) 4 (33.3) 41 (46.6) 0.387C
 Psychiatric comorbidities, no. (%) 21 (21) 4 (33.3) 17 (19.3) 0.271F
Associated FND, no. (%)
 Sensory functional symptoms 59 (59) 9 (75) 50 (56.8) 0.350F
 Functional seizures 24 (24) 2 (16.7) 22 (25) 0.725F
 Visual functional symptoms 26 (26) 3 (25) 23 (26.1) 1.000F
 Cognitive functional symptoms 60 (60) 7 (58.3) 53 (60.2) 1.000F
 Fibromyalgia 15 (15) 1 (8.3) 14 (15.9) 0.687F
 Functional bowel syndrome 12 (12) 1 (8.3) 11 (12.5) 1.000F
Precipitating factors, no. (%)
 Surgery 27 (27) 1 (8.3) 26 (29.5) 0.172F
 Physical trauma 27 (27) 3 (25) 24 (27.3) 1.000F
 Psychological trauma 28 (28) 3 (25) 25 (28.4) 1.000F
 General anesthesia 20 (20) 1 (8.3) 19 (21.6) 0.451F
 Infections 6 (6) 1 (8.3) 5 (5.7) 0.545F